- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Twist Bioscience Launches Express Screening Antibodies, Expanding Production and Characterization Portfolio | ||
| Mi | Novocure and Verastem to Test Combined Therapies for Locally Advanced Pancreatic Cancer | ||
| Mi | Piramal Pharma Solutions' Pithampur Site Links Every Batch to Patient | ||
| Mi | Enthorin Enters Option-to-License Pact with Rumi for Fragile X Syndrome Therapy | ||
| Mi | Astellas, Audax Ink Global License Agreement for Immuno-Oncology Candidate | ||
| Mi | Transpharmation Acquires OrganoTherapeutics, Advancing Novel CNS Therapies | ||
| Mi | Alcami Promotes Robert Tragas to Vice President of Lab Services | ||
| Di | Adalvo Acquires Romiplostim Biosimilar Program from Enzene | ||
| Di | Aptar Pharma, Stevanato Group Partner on Pre-Filled Syringe Configuration Assessments | ||
| Di | Teva Completes Acquisition of BioXcel Assets, Expands Neuroscience Pipeline | ||
| Di | AstraZeneca and Daiichi Sankyo's Enhertu Gets EU Nod for Residual Treatment in HER2+ Early Breast Cancer | ||
| Di | Humanitas Global Health Launches at AAPS PharmSci 360 | ||
| Di | DFE Pharma Appoints Peter Rose as New Chief Operating Officer | ||
| Mo | Regeneron Extends BARDA Deal for Ebola Treatment Supply for $270M Through 2031 | ||
| Mo | FDA Expands Approval of Pfizer's Talzenna Plus Xtandi for Earlier Prostate Cancer Treatment | ||
| Mo | Aurigene, Dr. Reddy's, Innoviva Specialty Therapeutics and GARDP Recognized at CPHI | ||
| Fr | Meissner Celebrates Ribbon-Cutting and Groundbreaking for Two Georgia Facilities | ||
| Fr | Roche Licenses Zymeworks' ZW209 Cancer Therapy | ||
| 22.10. | eGenesis Picks Daniel Leblanc as New Chief Manufacturing and Supply Officer | ||
| 22.10. | Antogen Opens Oklahoma City Laboratory to Help Scale Biopharma Services | ||
| 22.10. | ProBio Successfully Completes Pre-Approval Inspection of China Biologics Manufacturing Facility | ||
| 22.10. | Ardena Invests in New Compaction Simulator in Ghent | ||
| 22.10. | MVIC, Upperton Launch Integrated Drug Development Pathway | ||
| 22.10. | Resyca, Cyrano Report Positive Phase 2 Smell Loss Results | ||
| 22.10. | Recipharm Expands Sterile Manufacturing in Portugal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.